Revista CEFAC
https://revistacefac.org.br/article/doi/10.1590/1982-0216/20232553623
Revista CEFAC
Artigos Originais

Factors associated with mandibular function impairment in people with Parkinson’s disease during social isolation due to COVID-19

Haryssa Guimarães de Lima Feliciano; Jonatas Silva de Oliveira; Crislayne Felix da Silva; Tales Severiano da Silva; Raissa Barreto Tavares; Laiza de Oliveira Lucena; Maria das Graças Wanderley de Sales Coriolano; Carla Cabral dos Santos Accioly Lins

Downloads: 1
Views: 247

Abstract

Purpose: to analyze factors associated with mandibular function impairment in people with Parkinson’s disease during social isolation due to COVID-19.

Methods: this cross-sectional, quantitative, analytical study used a database with 115 records of patients presented with this condition (obtained via telemonitoring in a research conducted in 2020) and assessed sociodemographic aspects and the Mandibular Function Impairment Questionnaire (MFIQ). The variables addressed in the associations were sex, age, marital status, denture use, disease duration, and daily levodopa dose. Results were obtained with the Fisher´s exact test, with the significance level set at p < 0.05.

Results: after analyzing the database, the final sample comprised 62 eligible records - 61% were males, 79% were above 60 years old, 63% wore dentures, and 93% had low severity of mandibular function impairment, according to MFIQ. No significant associations were found between the study variables and MFIQ (p < 0.05).

Conclusion: the degree of mandibular impairment was low, and the study variables were not associated with mandibular function impairment in patients presented with Parkinson´s disease, during social isolation, due to COVID-19.

Keywords

Parkinson Disease; COVID-19; Pandemics; Signs and Symptoms; Aged

Referências

1. Souto XM. COVID-19: Aspectos gerais e implicações globais. RECITAL. 2020;2(1):12-36. https://doi.org/10.46636/recital.v2i1.90.

2. Matta GC, Rego S, Souto EP, Segata J. Os impactos sociais da Covid-19 no Brasil: populações vulnerabilizadas e respostas à pandemia. 1st ed. Rio de Janeiro: FIOCRUZ; 2021.

3. Hammerschmidt KSA, Santana RF. Saúde do Idoso em Tempos de Pandemia COVID-19. Cogitare enferm. 2020;25:e72849. http://dx.doi.org/10.5380/ce.v25i0.72849.

4. Silva TP, Carvalho CRA. Parkinson's Disease: The occupational therapeutic treatment in the perspective of professionals and elderly. Cad. Bras. Ter. Ocup. 2019;27(2):331-44. https://doi.org/10.4322/2526-8910.ctoAO1229.

5. Cabreira V, Massano J. Doença de Parkinson: Revisão Clínica e Atualizada. Acta Med Port. 2019;32(10):661-70. http://dx.doi.org/10.20344/amp.11978.

6. Rech RS, Goulart BNG, Baumgarten A, Hilgert JB. Deglutição no envelhecimento e a odontologia. RFO. 2018;23(1):77-83. https://doi.org/10.5335/rfo.v23i1.8508.

7. Silva TS, Oliveira JS, Faccio PF, Coriolano MGWS, Lins CCSA. Analysis of the relationship of the vertical extension of mouth opening with muscle rigidity and sociodemographic factors in Parkinson's disease. Rev odontol UNESP. 2021;50:e20210035. https://doi.org/10.1590/1807-2577.03521.

8. Silva CF, Oliveira JS, Silva TS, Silva Filho NJ, Marques VG, Tavares RB et al. Telemonitoring of the oral health condition of people with Parkinson's disease during the Covid-19 pandemic. Rev Odontol UNESP. 2022;51:e20220003. https://doi.org/10.1590/1807-2577.00322.

9. Chaves TC, Oliveira AS, Grossi DB. Principais instrumentos para avaliação da disfunção temporomandibular, parte I: índices e questionários; uma contribuição para a prática clínica e de pesquisa. Fisioter Pesq. 2008;15(1):92-100. https://doi.org/10.1590/S1809-29502008000100015.

10. Nunes AM, Lopes PRR, Bittencourt MAV, Araújo RPC. Association between severity of the temporomandibular disorder, neck pain, and mandibular function impairment. Rev. CEFAC. 2020;22(2):e17418. https://doi.org/10.1590/1982-0216/202022217418.

11. Lucena LO, Silva CF, Oliveira JS, Silva TS, Andrade MEFVB, Tavares RB et al. Avaliação da severidade da disfunção temporomandibular e da função mandibular em idosos com doença de Parkinson em tempos de COVID-19. Int J Dev Res. 2022;12(3):54490-94. https://doi.org/10.37118/ijdr.23811.03.2022.

12. Miele G, Straccia G, Moccia M, Leocani L, Tedeschi G, Bonavita S et al. Telemedicine in Parkinson's Disease: How to Ensure Patient Needs and Continuity of Care at the Time of COVID-19 Pandemic. Telemed J E Health. 2020;26(12):1533-6. https://doi.org/10.1089/tmj.2020.0184. PMID: 32667839.

13. Brasil. Lei nº 14.423, de 22 de Julho de 2022. Brasília: Constituição Federal. 2022[cited 2023 Feb03]. Available from: https://www2.camara.leg.br/legin/fed/lei/2022/lei-14423-22-julho-2022-793034-norma-pl.html.

14. Oliveira JS, Sobral AV, Silva TVA, Coriolano MGWS, Lins CCSA. Sociodemographic profile and stages of Parkinson's disease associated with predictors of Temporomandibular Disorder. Rev. CEFAC. 2021;23(2):e11220. https://doi.org/10.1590/1982-0216/202123.

15. Mora JLA, Curbelo VBG, Valladares EJB, Santiago FJDS. Increase in physical capacities balance and gait in elderly with Parkinson. Rev Podium. 2022;17(2):654-71.

16. Pinto ALC, Barroso LCC, Modesto WS, Melo RA, Moraes MGG, Moraes NS. Perfil epidemiológico de pacientes com doença de Parkinson em Belém do Pará. Res. Soc. Dev. 2022;11(6):e20411628851. https://doi.org/10.33448/rsd-v11i6.28851.

17. Fernandes I, Andrade Filho AS. Estudo Clínico-Epidemiológico de Pacientes com Doença de Parkinson em Salvador-Bahia. Rev Bras de Neurol e Psiquiatr. 2018;22(1):45-59.

18. Magno L, Rossi TA, Mendonça-Lima FW, Santos CC, Campos GB, Marques LM et al. Challenges and proposals for scaling up COVID-19 testing and diagnosis in Brazil. Ciênc. Saúde Colet. 2020;25(9):3355-64. https://doi.org/10.1590/1413-81232020259.17812020.

19. Maia LC, Costa SM, Martelli DRB, Caldeira AP. Total edentulism in older adults: aging or social inequality? Rev Bioét. 2020;28(1):173-81. https://doi.org/10.1590/1983-80422020281380.

20. Costa TR, Esteves RA, Pedrosa SS, Gauch LMR. A importância da reabilitação oral na qualidade de vida do idoso: relato de caso. Revista Digital APO. 2020;4(2):36-45. https://doi.org/10.5935/2526-8155.20200005.

21. Silva ABG, Pestana BC, Hirahata FAA, Horta FBS, Oliveira ESBE. Doença de Parkinson: revisão de literatura. Braz J Dev. 2021;7(5):47677-98. https://doi.org/10.34117/bjdv.v7i5.29678.

22. Sá CS, RodriguesJunior OM. Pharmacotherapeutic follow-up to patients with Parkinson's disease using the drugs Levodopa and Biperidin hydrochloride: Interactions in drug treatment. Res. Soc. Dev. 2022;11(15):2525-3409. https://doi.org/10.33448/rsd-v11i15.36721.

23. Frank C, Chiu R, Lee J. Parkinson disease primer, part 2: management of motor and nonmotor symptoms. Can Fam Physician. 2023;69(2):91-6. https://doi.org/10.46747%2Fcfp.690291. PMID: 36813521.
 


Submetido em:
20/04/2023

Aceito em:
27/07/2023

65bb9264a9539521556c1e94 cefac Articles
Links & Downloads

Revista CEFAC

Share this page
Page Sections